CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
enhanced with continuous glucose monitor (CGM) review to target diabetes distress in adults with type 1 diabetes. The efficacy of C...
New York, New York, United States and 1 other location
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
New York, New York, United States and 22 other locations
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...
Linden, New Jersey, United States and 43 other locations
The overall purpose of the study is to test the effect of Noom on exercise and diet advice in adults with type 2 diabetes. The overarching h...
New Brunswick, New Jersey, United States and 2 other locations
Pregnant women aged 18-49 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments ...
Phase 2, Phase 3
New York, New York, United States and 4 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...
New York, New York, United States and 64 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Smithtown, New York, United States and 35 other locations
enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes...
Bronx, New York, United States of America and 1 other location
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
New York, New York, United States and 54 other locations
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals ...
Phase 2, Phase 3
Hackensack, New Jersey, United States and 1 other location
Clinical trials
Research sites
Resources
Legal